Literature DB >> 8993835

Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway.

D Kothapalli1, K S Frazier, A Welply, P R Segarini, G R Grotendorst.   

Abstract

Connective tissue growth factor (CTGF) is a M(r)38,000 cysteine-rich peptide, the synthesis and secretion of which are selectively induced by transforming growth factor beta (TGF-beta). The relationship of CTGF to TGF-beta action on fibroblastic cells is not well understood. TGF-beta has the unique ability to stimulate the growth of normal fibroblasts in soft agar, a property of transformed cells. We have investigated whether CTGF can substitute for TGF-beta or whether CTGF action is essential for TGF-beta to stimulate anchorage-independent growth (AIG) of NRK fibroblasts. Our studies demonstrate that CTGF cannot induce AIG of NRK fibroblasts. However, CTGF synthesis and action are essential for the TGF-beta-induced AIG of NRK fibroblasts. Anti-CTGF antibodies specifically block TGF-beta-induced AIG but have no effect on platelet-derived growth factor or epidermal growth factor-induced growth in monolayer cultures and do not cross-react with platelet-derived growth factor or TGF-beta. Clones of NRK fibroblasts that express an antisense CTGF gene (NRK-ASCTGF), which blocks the expression of the endogenous CTGF gene, do not respond to TGF-beta in the AIG assay. The growth and morphology of the cells (NRK-ASCTGF) in monolayer culture are unaltered from the parent NRK cell line. The addition of recombinant CTGF to the NRK-ASCTGF clones in the presence of TGF-beta restores the AIG response of the cells. These studies demonstrate that the TGF-beta stimulation of NRK fibroblast AIG is dependent on events induced via the synergistic action of CTGF-dependent and CTGF-independent signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8993835

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  38 in total

Review 1.  Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.

Authors:  Justin C Hewlett; Jonathan A Kropski; Timothy S Blackwell
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

2.  Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation.

Authors:  R Zhang; L Averboukh; W Zhu; H Zhang; H Jo; P J Dempsey; R J Coffey; A B Pardee; P Liang
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

3.  Regulation of fibronectin-EDA through CTGF domain-specific interactions with TGFβ2 and its receptor TGFβRII.

Authors:  Rima Khankan; Noelynn Oliver; Shikun He; Stephen J Ryan; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-07       Impact factor: 4.799

4.  A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).

Authors:  Mark Brian Sherwood
Journal:  Trans Am Ophthalmol Soc       Date:  2006

5.  The clinical value of serum connective tissue growth factor in the assessment of liver fibrosis.

Authors:  Dai Zhang; Nian-Yue Wang; Cheng-Bao Yang; Guo-Xiang Fang; Wei Liu; Jian Wen; Chan Luo
Journal:  Dig Dis Sci       Date:  2009-03-18       Impact factor: 3.199

6.  Posttranscriptional regulation of chicken ccn2 gene expression by nucleophosmin/B23 during chondrocyte differentiation.

Authors:  Yoshiki Mukudai; Satoshi Kubota; Harumi Kawaki; Seiji Kondo; Takanori Eguchi; Kumi Sumiyoshi; Toshihiro Ohgawara; Tsuyoshi Shimo; Masaharu Takigawa
Journal:  Mol Cell Biol       Date:  2008-08-04       Impact factor: 4.272

7.  Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes.

Authors:  Young-Sam Lee; Jeong-A Kim; Koung Li Kim; Hyung-Suk Jang; Jeong-Min Kim; Jae-Young Lee; In-Soon Shin; Jung-Sun Lee; Wonhee Suh; Jin-Ho Choi; Eun-Seok Jeon; Jonghoe Byun; Duk-Kyung Kim
Journal:  J Korean Med Sci       Date:  2004-12       Impact factor: 2.153

8.  Complement C5 regulates the expression of insulin-like growth factor binding proteins in chronic experimental allergic encephalomyelitis.

Authors:  Cornelia Cudrici; Takahiro Ito; Ekaterina Zafranskaia; Susanna Weerth; Violeta Rus; Hegang Chen; Florin Niculescu; Katerina Soloviova; Cosmin Tegla; Adrian Gherman; Cedric S Raine; Moon L Shin; Horea Rus
Journal:  J Neuroimmunol       Date:  2008-10-15       Impact factor: 3.478

Review 9.  Noncanonical transforming growth factor beta signaling in scleroderma fibrosis.

Authors:  Maria Trojanowska
Journal:  Curr Opin Rheumatol       Date:  2009-11       Impact factor: 5.006

10.  Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta.

Authors:  José G Abreu; Nan I Ketpura; Bruno Reversade; E M De Robertis
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.